1. Home >
  2. M&A >
  3. Add-on Acquisition >
  4. United Kingdom >
  5. Odyssey Therapeutics Acquires Rahko

M&A Deal Summary

Odyssey Therapeutics Acquires Rahko

On January 6, 2022, Odyssey Therapeutics acquired information technology company Rahko

Acquisition Highlights
  • This is Odyssey Therapeutics’ 1st transaction in the Information Technology sector.
  • This is Odyssey Therapeutics’ 1st transaction in the United Kingdom.

M&A Deal Summary
Date 2022-01-06
Target Rahko
Sector Information Technology
Buyer(s) Odyssey Therapeutics
Deal Type Add-on Acquisition

Target

Rahko

London, United Kingdom
Rahko is a quantum machine learning company cutting the cost and time to discover and develop new drugs. Rahko was founded in 2018 and is based in London, United Kingdom.

Search 214,239 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Odyssey Therapeutics

Boston, Massachusetts, United States
Category Company
Founded 2021
Sector Life Science
DESCRIPTION

Odyssey Therapeutics is a biotechnology company that develops next generation immunomodulators and oncology medicines. Odyssey Therapeutics was founded in 2021 and is based in Boston, Massachusetts.

DEAL STATS #
Overall 1 of 1
Sector: Information Technology M&A 1 of 1
Type: Add-on Acquisition M&A Deals 1 of 1
Country: United Kingdom M&A 1 of 1
Year: 2022 M&A 1 of 1
Mergr

Solution for

Product

Company

Legal